Rita J Desai
Examiner (ID: 14900, Phone: (571)272-0684 , Office: P/1625 )
Most Active Art Unit | 1625 |
Art Unit(s) | 1612, 1625 |
Total Applications | 2152 |
Issued Applications | 1290 |
Pending Applications | 146 |
Abandoned Applications | 716 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 7270427
[patent_doc_number] => 20040058945
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'N-type calcium channel antagonists for the treatment of pain'
[patent_app_type] => new
[patent_app_number] => 10/415785
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16213
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415785
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415785 | N-type calcium channel antagonists for the treatment of pain | Oct 1, 2003 | Issued |
Array
(
[id] => 7281343
[patent_doc_number] => 20040063720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Tyrosine kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/677687
[patent_app_country] => US
[patent_app_date] => 2003-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34795
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063720.pdf
[firstpage_image] =>[orig_patent_app_number] => 10677687
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/677687 | Tyrosine kinase inhibitors | Oct 1, 2003 | Issued |
Array
(
[id] => 1080783
[patent_doc_number] => 06835741
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-28
[patent_title] => 'Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists'
[patent_app_type] => B2
[patent_app_number] => 10/673100
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60338
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/835/06835741.pdf
[firstpage_image] =>[orig_patent_app_number] => 10673100
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/673100 | Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists | Sep 25, 2003 | Issued |
Array
(
[id] => 5656841
[patent_doc_number] => 20060142577
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-06-29
[patent_title] => 'Novel pyrimidineamide derivatives and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/528913
[patent_app_country] => US
[patent_app_date] => 2003-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18211
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20060142577.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528913
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528913 | Pyrimidineamide derivatives and the use thereof | Sep 25, 2003 | Issued |
Array
(
[id] => 7190339
[patent_doc_number] => 20040204386
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-10-14
[patent_title] => 'Pyrimidines and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/671070
[patent_app_country] => US
[patent_app_date] => 2003-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47403
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0204/20040204386.pdf
[firstpage_image] =>[orig_patent_app_number] => 10671070
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/671070 | Pyrimidines and uses thereof | Sep 23, 2003 | Issued |
Array
(
[id] => 7337193
[patent_doc_number] => 20040132746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-08
[patent_title] => 'Inhibitors of cyclin dependent kinases as anti-cancer agent'
[patent_app_type] => new
[patent_app_number] => 10/671747
[patent_app_country] => US
[patent_app_date] => 2003-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 16488
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20040132746.pdf
[firstpage_image] =>[orig_patent_app_number] => 10671747
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/671747 | Inhibitors of cyclin dependent kinases as anti-cancer agent | Sep 23, 2003 | Issued |
Array
(
[id] => 7291109
[patent_doc_number] => 20040110757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis'
[patent_app_type] => new
[patent_app_number] => 10/472631
[patent_app_country] => US
[patent_app_date] => 2003-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7919
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110757.pdf
[firstpage_image] =>[orig_patent_app_number] => 10472631
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/472631 | Flt-1 ligands and their uses in the treatment of diseases regulatable by angiogenesis | Sep 21, 2003 | Abandoned |
Array
(
[id] => 7612617
[patent_doc_number] => 06903218
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-06-07
[patent_title] => 'Sulfonamide substituted chroman derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/667286
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29573
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 4
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/903/06903218.pdf
[firstpage_image] =>[orig_patent_app_number] => 10667286
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/667286 | Sulfonamide substituted chroman derivatives | Sep 18, 2003 | Issued |
Array
(
[id] => 7281338
[patent_doc_number] => 20040063715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Novel imidazopyrazines as cyclin dependent kinase inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/665005
[patent_app_country] => US
[patent_app_date] => 2003-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12958
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063715.pdf
[firstpage_image] =>[orig_patent_app_number] => 10665005
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/665005 | Imidazopyrazines as cyclin dependent kinase inhibitors | Sep 18, 2003 | Issued |
Array
(
[id] => 5771663
[patent_doc_number] => 20050267114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient'
[patent_app_type] => utility
[patent_app_number] => 10/527435
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63313
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20050267114.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527435
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527435 | Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient | Sep 16, 2003 | Abandoned |
Array
(
[id] => 5808382
[patent_doc_number] => 20060094737
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-04
[patent_title] => 'Novel uracil derivatives and medicinal use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/528373
[patent_app_country] => US
[patent_app_date] => 2003-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16670
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20060094737.pdf
[firstpage_image] =>[orig_patent_app_number] => 10528373
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/528373 | Novel uracil derivatives and medicinal use thereof | Sep 16, 2003 | Abandoned |
Array
(
[id] => 7281310
[patent_doc_number] => 20040063687
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-01
[patent_title] => 'Heterocyclic dihydropyrimidine compounds'
[patent_app_type] => new
[patent_app_number] => 10/660878
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40974
[patent_no_of_claims] => 60
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20040063687.pdf
[firstpage_image] =>[orig_patent_app_number] => 10660878
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/660878 | Heterocyclic dihydropyrimidine compounds | Sep 11, 2003 | Issued |
Array
(
[id] => 7355292
[patent_doc_number] => 20040048850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them'
[patent_app_type] => new
[patent_app_number] => 10/660489
[patent_app_country] => US
[patent_app_date] => 2003-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9232
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048850.pdf
[firstpage_image] =>[orig_patent_app_number] => 10660489
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/660489 | Substituted 4-amino-2-arylcyclopenta[d]pyrimidines, their preparation, their use and pharmaceutical preparations comprising them | Sep 11, 2003 | Issued |
Array
(
[id] => 7389084
[patent_doc_number] => 20040030134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-02-12
[patent_title] => 'Process for preparation of integrin receptor antagonist intermediates'
[patent_app_type] => new
[patent_app_number] => 10/398364
[patent_app_country] => US
[patent_app_date] => 2003-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8014
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0030/20040030134.pdf
[firstpage_image] =>[orig_patent_app_number] => 10398364
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/398364 | Process for preparation of integrin receptor antagonist intermediates | Sep 10, 2003 | Abandoned |
Array
(
[id] => 830209
[patent_doc_number] => 07399763
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-07-15
[patent_title] => '8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as HIV integrase inhibitors'
[patent_app_type] => utility
[patent_app_number] => 10/526280
[patent_app_country] => US
[patent_app_date] => 2003-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18243
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/399/07399763.pdf
[firstpage_image] =>[orig_patent_app_number] => 10526280
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/526280 | 8-hydroxy-1-oxo-tetrahydropyrrolopyrazine compounds useful as HIV integrase inhibitors | Sep 9, 2003 | Issued |
Array
(
[id] => 585833
[patent_doc_number] => 07442694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-10-28
[patent_title] => 'Diazabicyclic compounds useful in the treatment of CNS and other disorders'
[patent_app_type] => utility
[patent_app_number] => 10/657738
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25552
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/442/07442694.pdf
[firstpage_image] =>[orig_patent_app_number] => 10657738
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/657738 | Diazabicyclic compounds useful in the treatment of CNS and other disorders | Sep 7, 2003 | Issued |
Array
(
[id] => 7310550
[patent_doc_number] => 20040142927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-07-22
[patent_title] => 'Inhibitors of p38'
[patent_app_type] => new
[patent_app_number] => 10/658111
[patent_app_country] => US
[patent_app_date] => 2003-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9123
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20040142927.pdf
[firstpage_image] =>[orig_patent_app_number] => 10658111
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/658111 | Inhibitors of p38 | Sep 7, 2003 | Issued |
Array
(
[id] => 7291271
[patent_doc_number] => 20040110780
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-06-10
[patent_title] => 'Pyrimidine derivatives useful in the treatment of insulin resistance and hyperglycemia'
[patent_app_type] => new
[patent_app_number] => 10/655471
[patent_app_country] => US
[patent_app_date] => 2003-09-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6346
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20040110780.pdf
[firstpage_image] =>[orig_patent_app_number] => 10655471
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/655471 | Pyrimidine derivatives useful in the treatment of insulin resistance and hyperglycemia | Sep 3, 2003 | Issued |
Array
(
[id] => 7170538
[patent_doc_number] => 20040077859
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-04-22
[patent_title] => 'Immunosuppressive effects of pteridine derivatives'
[patent_app_type] => new
[patent_app_number] => 10/651604
[patent_app_country] => US
[patent_app_date] => 2003-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 27677
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0077/20040077859.pdf
[firstpage_image] =>[orig_patent_app_number] => 10651604
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/651604 | Immunosuppressive effects of pteridine derivatives | Aug 28, 2003 | Issued |
Array
(
[id] => 5596883
[patent_doc_number] => 20060160801
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-20
[patent_title] => 'Pyrimidinone derivaties as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes'
[patent_app_type] => utility
[patent_app_number] => 10/527391
[patent_app_country] => US
[patent_app_date] => 2003-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17378
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20060160801.pdf
[firstpage_image] =>[orig_patent_app_number] => 10527391
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/527391 | Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes | Aug 27, 2003 | Issued |